in

COVID-19, Public health ethics and policy in the event of a pandemic



September 11, 2020 Since the start of the pandemic, scientific recommendations on how best to reduce its impact have met with broad resistance in the U.S. With two in the epidemiology and ethics of infectious diseases, we will examine how scientific evidence is collected in a rapidly changing public health environment, and how to translate that evidence into actionable recommendations. We will also discuss the sources of controversies that have arisen as the pandemic has evolved, including balancing individual and public health interests and how to deal with different types of uncertainty. Presented by Marc Lipsitch, DPhil Matthew Wynia, MD, MPH Moderated by Leah Rand, PhD, MA Organized by the Harvard Medical School Center for Bioethics and the Program on Regulation, Therapeutics, and Law (PORTAL) at Brigham and ’s Hospital, in collaboration with the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School. .
#COVID19 #Public #health #ethics #policy #event #pandemic

In the worst months of the pandemic, major banks charged billions in overdrafts

Millions of people skip second dose of Covid vaccine in US – Dateway